r/stocks
Potential Type 1 Diabetes Cure
Eledon Pharma reports 100% insulin independence in small T1D study; sees huge growth/acquisition potential despite low market cap.
- Phase 2 data shows 100% efficacy (12/12 patients) achieving insulin independence, a potential functional cure for T1D.
- Low market cap ($275M) offers significant upside multiple expansion if larger trials confirm results.
- Strong acquisition target for major pharma companies seeking to diversify beyond GLP-1s into high-unmet-need areas.
- Sample size is extremely small (n=12), making statistical significance and generalizability uncertain until larger trials.
- Regulatory path for 'functional cure' claims is complex and lengthy, posing execution risk.
- Market skepticism may persist due to history of failed diabetes cures, limiting immediate price appreciation.
Eledon Pharmaceuticals just announced the results of their study where 100% of patients achieved insulin independence (all 12 patients) that had type 1 diabetes. They have a market capitalization of $275 million so there is a ton of room to grow or even become an acquisition target by a larger company looking to replenish its revenues. Apparently there are over 2.1 million people with diagnosed type 1 diabetes in the US alone so this could be a massive opportunity. Seems like the market isn’t giving it the recognition it deserves as it will probably need a bigger clinical trial. I think this should revive the same standing ovation as the pancreatic cancer drug did if the larger trial comes back with the same results.
Link is below with the press release.
https://ca.finance.yahoo.com/news/eledon-announces-updated-data-investigator-110000620.html
Sorry - the post you're trying to make mentions a stock that currently breaks rule #7.
Any of the following criteria is considered breaking the rule:
- Typically trades under $5 or previously traded under $5 within 6 months
- Below $300 million market cap or previously traded under 300m before the pump within 6 months
- Most OTC / PINK stocks
- Usually has missed reporting/filings; no auditing or odd auditing issues
- Low volume or wide bid/ask spread
- Doesn't have any big name institutional holders
* If the biggest institutional holder is a stock promoter then they don't count as an institutional holder
- All SPACs
You can learn more about rule #7 here: https://www.reddit.com/r/stocks/wiki/pennystocks